Advertisement
Sertraline treatment does not significantly improve depressive symptoms among patients with non-dialysis-dependent chronic kidney disease and major depressive disorder

Sertraline Treatment No Benefit for Depressive Symptoms in CKD

0
No improvement for patients with MDD and chronic kidney disease without dialysis dependence
Total physical activity (PA) and moderate- to vigorous-intensity PA are inversely associated with mortality

Intensity of Exercise Affects Impact on Mortality Risk

0
Findings support recommendation of moderate- to vigorous-intensity physical activity
For patients with rheumatoid arthritis

ACR: Opioids, SSRIs Tied to Higher Fracture Risk in RA

0
Increased risk of osteoporotic fracture with selective serotonin reuptake inhibitors, opioids of any strength
Pricing interventions seem to improve access to healthy food and beverage options with increases in stocking and sales of these items

Pricing Interventions Increase Sales, Intake of Healthy Foods

0
Also linked to reduced purchasing and consumption of unhealthy foods and beverages

The American Society of Reproductive Medicine, Oct. 28- Nov. 1

0
The 73rd Annual Meeting of the American Society for Reproductive Medicine (ASRM) The annual meeting of the American Society for Reproductive...
Postmenopausal estradiol therapy may protect certain types of cognition in the presence of stress

Postmenopausal Estradiol Linked to Blunted Cortisol Responses

0
May protect certain cognitive processes against stress exposure
The central effects of glucagon-like peptide-1 may mediate the effects of Roux-en-Y gastric bypass on central nervous system activation in response to visual and gustatory food cues

GLP-1 May Mediate Effects of Gastric Bypass on CNS Activation

0
After Roux-en-Y, CNS activation reduced in response to food cues, GLP-1 levels significantly elevated
Not all prescription drug users report receiving warnings about driving impairment

Driving Impairment Warnings Often Not Given With Rx Meds

0
For most drug categories, those who do receive warnings perceive higher risk of impaired driving
Systemic inflammation in midlife is associated with future neurodegeneration and cognitive aging

Midlife Systemic Inflammation Tied to Late-Life Brain Volume

0
Smaller hippocampal, Alzheimer's signature region volumes seen 24 years after inflammation noted
Specific inflammatory biomarkers may impact the risk of developing schizophrenia

Inflammatory Biomarkers May Impact Risk of Schizophrenia

0
Protective effect noted for C-reactive protein; risk-increasing effect for soluble interleukin-6 receptor